Catalyst Wire Dossier Catalyst Wire Dossier

Spravato (esketamine)

esketamine · Janssen Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Spravato (esketamine), covering 2014-03-13 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Esketamine on Postoperative Sleep in Postmenopausal Women [NA]

See pricing